Literature DB >> 36156906

The Yin and Yang of the protein corona on the delivery journey of nanoparticles.

Yi-Feng Wang1,2, Yaxin Zhou3, JiaBei Sun4, Xiaotong Wang5, Yaru Jia5, Kun Ge5, Yan Yan6, Kenneth A Dawson1,6, Shutao Guo3, Jinchao Zhang5, Xing-Jie Liang1,2,5.   

Abstract

Nanoparticles-based drug delivery systems have attracted significant attention in biomedical fields because they can deliver loaded cargoes to the target site in a controlled manner. However, tremendous challenges must still be overcome to reach the expected targeting and therapeutic efficacy in vivo. These challenges mainly arise because the interaction between nanoparticles and biological systems is complex and dynamic and is influenced by the physicochemical properties of the nanoparticles and the heterogeneity of biological systems. Importantly, once the nanoparticles are injected into the blood, a protein corona will inevitably form on the surface. The protein corona creates a new biological identity which plays a vital role in mediating the bio-nano interaction and determining the ultimate results. Thus, it is essential to understand how the protein corona affects the delivery journey of nanoparticles in vivo and what we can do to exploit the protein corona for better delivery efficiency. In this review, we first summarize the fundamental impact of the protein corona on the delivery journey of nanoparticles. Next, we emphasize the strategies that have been developed for tailoring and exploiting the protein corona to improve the transportation behavior of nanoparticles in vivo. Finally, we highlight what we need to do as a next step towards better understanding and exploitation of the protein corona. We hope these insights into the "Yin and Yang" effect of the protein corona will have profound implications for understanding the role of the protein corona in a wide range of nanoparticles. © Tsinghua University Press 2022.

Entities:  

Keywords:  bio-nano interaction; biological identity; drug delivery; nanoparticles; protein corona

Year:  2022        PMID: 36156906      PMCID: PMC9483491          DOI: 10.1007/s12274-022-4849-6

Source DB:  PubMed          Journal:  Nano Res        ISSN: 1998-0000            Impact factor:   10.269


  133 in total

1.  Unmasking CSF protein corona: Effect on targeting capacity of nanoparticles.

Authors:  Yazhen Wang; Huilin Zhang; Wei Xiao; Yuwei Liu; Yang Zhou; Xueqin He; Xue Xia; Tao Gong; Ling Wang; Huile Gao
Journal:  J Control Release       Date:  2021-04-03       Impact factor: 9.776

Review 2.  Protein Corona-Enabled Systemic Delivery and Targeting of Nanoparticles.

Authors:  Dongyu Chen; Shanthi Ganesh; Weimin Wang; Mansoor Amiji
Journal:  AAPS J       Date:  2020-06-03       Impact factor: 4.009

3.  Dually Enzyme- and Acid-Triggered Self-Immolative Ketal Glycoside Nanoparticles for Effective Cancer Prodrug Monotherapy.

Authors:  Na Yu; Tao Liu; Xi Zhang; Ningqiang Gong; Tianjiao Ji; Jing Chen; Xing-Jie Liang; Daniel S Kohane; Shutao Guo
Journal:  Nano Lett       Date:  2020-06-23       Impact factor: 11.189

4.  Protein corona significantly reduces active targeting yield.

Authors:  Vahid Mirshafiee; Morteza Mahmoudi; Kaiyan Lou; Jianjun Cheng; Mary L Kraft
Journal:  Chem Commun (Camb)       Date:  2013-03-28       Impact factor: 6.222

5.  Transferrin-functionalized nanoparticles lose their targeting capabilities when a biomolecule corona adsorbs on the surface.

Authors:  Anna Salvati; Andrzej S Pitek; Marco P Monopoli; Kanlaya Prapainop; Francesca Baldelli Bombelli; Delyan R Hristov; Philip M Kelly; Christoffer Åberg; Eugene Mahon; Kenneth A Dawson
Journal:  Nat Nanotechnol       Date:  2013-01-20       Impact factor: 39.213

6.  Polyethylene glycol backfilling mitigates the negative impact of the protein corona on nanoparticle cell targeting.

Authors:  Qin Dai; Carl Walkey; Warren C W Chan
Journal:  Angew Chem Int Ed Engl       Date:  2014-04-02       Impact factor: 15.336

Review 7.  Nanomedicine as a promising approach for diagnosis, treatment and prophylaxis against COVID-19.

Authors:  Noura H Abd Ellah; Sheryhan F Gad; Khalid Muhammad; Gaber E Batiha; Helal F Hetta
Journal:  Nanomedicine (Lond)       Date:  2020-07-29       Impact factor: 5.307

8.  pH-responsive high stability polymeric nanoparticles for targeted delivery of anticancer therapeutics.

Authors:  L Palanikumar; Sumaya Al-Hosani; Mona Kalmouni; Vanessa P Nguyen; Liaqat Ali; Renu Pasricha; Francisco N Barrera; Mazin Magzoub
Journal:  Commun Biol       Date:  2020-03-03

9.  Corona Composition Can Affect the Mechanisms Cells Use to Internalize Nanoparticles.

Authors:  Valentina Francia; Keni Yang; Sarah Deville; Catharina Reker-Smit; Inge Nelissen; Anna Salvati
Journal:  ACS Nano       Date:  2019-09-23       Impact factor: 15.881

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.